Saracatinib is a chemical compound widely used in cancer research to inhibit the growth of cancer cells. As a tyrosine kinase inhibitor, it functions by blocking the activity of proteins involved in cell signaling pathways that drive cell proliferation. This makes it a crucial tool in cell biology and cancer therapy studies. In laboratory settings, Saracatinib is employed to investigate the mechanisms of cancer progression and to evaluate the effectiveness of potential therapeutic agents. Its role in experimental research is pivotal for understanding the molecular basis of cancer and developing targeted treatment strategies.
The properties that make Saracatinib a preferred choice include its high purity and consistent formulation, ensuring reliable and reproducible experimental results. It is chemically stable and soluble in organic solvents, which facilitates its use in various analytical methods such as biological activity assays and toxicity testing. These characteristics make it a versatile compound for researchers seeking precision and accuracy in their experiments. Its stability and solubility also simplify handling and integration into complex chemical reactions, enhancing its utility in diverse laboratory applications.
In Indonesian laboratories, Saracatinib is commonly used in cancer research and drug development projects. It is a key component in experiments aimed at understanding cancer cell behavior and testing new therapeutic approaches. Its availability and reliability make it a popular choice among researchers working in both academic and industrial settings. The compound's consistent performance supports the pursuit of scientific advancements in oncology and related fields.
- Cancer Cell Growth Inhibition: Saracatinib is used to study the effects of tyrosine kinase inhibition on cancer cell proliferation, helping researchers understand tumor progression and potential treatment responses.
- Drug Efficacy Testing: It serves as a standard compound in assays evaluating the effectiveness of new cancer therapies, providing a reliable reference for comparative studies.
- Toxicity Assessment: Saracatinib is employed in toxicity testing to determine the safety profile of potential pharmaceutical compounds and their impact on cellular function.
- Molecular Mechanism Research: Its role as a kinase inhibitor makes it ideal for investigating signaling pathways involved in cancer development and progression.
- Cell Signaling Studies: It is used to explore the molecular mechanisms underlying cell communication and how disruptions in these pathways contribute to malignancy.
| Brand | TCI |
|---|---|
| CAS number | 379231-04-6 |
| Molecular formula | — |
| Purity | — |
| Category | Life Science > Cell Biology > Cancer Research |
| Pack sizes | Available in various quantities as per standard laboratory supply formats |
| Physical form | Solid powder |
| Storage | Store in a cool, dry place away from light and moisture |
Saracatinib should be stored in a cool, dry environment, away from direct sunlight and moisture to maintain its chemical stability. It is recommended to use airtight containers to prevent exposure to air and contaminants. Due to its organic solubility, it is important to handle the compound in a well-ventilated area to minimize inhalation risks. Researchers should wear appropriate personal protective equipment, including gloves and safety goggles, when handling Saracatinib. Proper disposal methods should be followed to ensure compliance with laboratory safety protocols and environmental regulations. The compound's stability and solubility characteristics make it manageable in standard laboratory conditions, provided standard safety measures are observed.
—






